IBM:s Watson-AI allt bättre på cancerbehandling
IBM:s datorsystem för artificiell intelligens, Watson, blir allt duktigare på att ta fram behandlingsplaner för cancer av en mängd olika slag. Det visar ny data som presenterats vid en årlig läkarkonferens. Watsons egna förslag på behandlingsplaner rimmar med mänskliga läkares rekommendationer i mycket hög grad. När det gäller lungcancer ligger siffran på 96 procent. När det gäller cancer i tarmarna handlar det om 81 procent.
”Studien som gjorts visar att Watson gör precis det vi förväntat oss” konstaterar Watsons hälsochef Andrew Norden, som också avslöjat att Watson inom kort ska kunna utvärdera behandlingsplaner för fler typer av cancer.
Watson (computer)
Wikipedia (en)
Watson is a question answering computer system capable of answering questions posed in natural language, developed in IBM's DeepQA project by a research team led by principal investigator David Ferrucci. Watson was named after IBM's first CEO, industrialist Thomas J. Watson. The computer system was specifically developed to answer questions on the quiz show Jeopardy! In 2011, Watson competed on Jeopardy! against former winners Brad Rutter and Ken Jennings. Watson received the first place prize of $1 million.
Watson had access to 200 million pages of structured and unstructured content consuming four terabytes of disk storage including the full text of Wikipedia, but was not connected to the Internet during the game. For each clue, Watson's three most probable responses were displayed on the television screen. Watson consistently outperformed its human opponents on the game's signaling device, but had trouble in a few categories, notably those having short clues containing only a few words.
In February 2013, IBM announced that Watson software system's first commercial application would be for utilization management decisions in lung cancer treatment at Memorial Sloan Kettering Cancer Center, New York City, in conjunction with health insurance company WellPoint. IBM Watson's former business chief, Manoj Saxena, says that 90% of nurses in the field who use Watson now follow its guidance.
Omni är politiskt obundna och oberoende. Vi strävar efter att ge fler perspektiv på nyheterna. Har du frågor eller synpunkter kring vår rapportering? Kontakta redaktionen